Hantz Financial Services »

Galectin Therapeutics shares owned by Hantz Financial Services

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Hantz Financial Services from 13F filings

Historical chart of Hantz Financial Services investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Hantz Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Hantz Financial Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.0k 2.1k 4.32